<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-section" /><meta name="keywords" content="Proton pump inhibitors; Zollinger-Ellison syndrome" /><meta name="IX" content="Proton pump inhibitors; Zollinger-Ellison syndrome" /><title>1.3.5 Proton pump inhibitors: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="2137.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="2137.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=2137.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1001.htm">1 Gastro-intestinal system</a> &gt; <a href="2015.htm">1.3 Antisecretory drugs and mucosal protectants</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2134.htm" title="Previous: MISOPROSTOL">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="88867.htm" title="Next: ESOMEPRAZOLE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>BNF for Children</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2137.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">1.3.5 Proton pump inhibitors</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.3 Antisecretory drugs and mucosal protectants</p></div></li></ul><ul><li><h3>Dietary Supplements</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c98.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vitamin B12</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/670-a8-4-v.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antisecretory drugs</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Gastrointestinal Drugs &gt; Gastrointestinal Drug Groups</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/670-a7-13-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Zollinger-Ellison syndrome</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Gastrointestinal Drugs &gt; Management of Gastrointestinal Disorders</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D97.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Proton pump inhibitors</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; P</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_2137">1.3.5 Proton pump inhibitors</h1><?highlighter on?><div id="pC" class="jN"><div><p>Proton pump inhibitors inhibit gastric acid secretion by blocking
the hydrogen-potassium <span>adenosine</span> triphosphatase
enzyme system (the ‘proton pump’) of the gastric parietal cell. Proton
pump inhibitors are effective short-term treatments for <i>gastric</i> and <i>duodenal ulcers</i>; they are also used in combination
with antibacterials for the eradication of <i>Helicobacter pylori</i> (see <a title="monograph-family: Recommended regimens for Helicobacter pylori eradication" href="73280.htm#_73280">Recommended Regimens for <span class="cAC">Helicobacter pylori</span> Eradication</a>). Following endoscopic treatment of severe peptic ulcer bleeding,
an intravenous, high-dose proton pump inhibitor reduces the risk of
rebleeding and the need for surgery. Proton pump inhibitors can be
used for the treatment of <a title="topic: Dyspepsia" href="100018.htm#_100018"><i>dyspepsia</i></a> and <a title="monograph-family: Gastro-oesophageal reflux disease" href="100063.htm#_100063"><i>gastro-oesophageal
reflux disease</i></a>.</p><p>Proton pump inhibitors are also used for the prevention and
treatment of NSAID-associated ulcers (see <a title="monograph-family: NSAID-associated ulcers" href="60265.htm#_60265">NSAID-associated Ulcers</a>). In patients who need to continue NSAID treatment
after an ulcer has healed, the dose of proton pump inhibitor should
normally not be reduced because asymptomatic ulcer deterioration may
occur.</p><p>A proton pump inhibitor can be used to reduce the degradation
of pancreatic enzyme supplements (<a title="BNF:sub-section: Pancreatin" href="2297.htm#_2297">section 1.9.4</a>) in patients with cystic fibrosis.
They can also be used to control excessive secretion of gastric acid
in <i>Zollinger–Ellison
syndrome</i>; high doses are often required.</p><div id="_2137.1"><div class="cAZ"><h2>Cautions</h2> <p class="cAX">Proton pump inhibitors may mask the symptoms
of gastric cancer; particular care is required in those presenting
with ‘alarm features’ (see <a title="dyspepsia" href="100018.htm#_100018">Dyspepsia</a>), in such cases gastric malignancy should be
ruled out before treatment. A proton pump inhibitor should be prescribed for appropriate
indications at the lowest effective dose for the shortest period; the need for long-term treatment should be reviewed
periodically.</p></div></div><div id="_200909"><div class="cAZ"><h2>Side-effects</h2> <p class="cAX">Side-effects of the proton pump inhibitors
include gastro-intestinal disturbances (including nausea, vomiting,
abdominal pain, flatulence, diarrhoea, constipation), and headache.
Less frequent side-effects include dry mouth, peripheral oedema, dizziness,
sleep disturbances, fatigue, paraesthesia, arthralgia, myalgia, rash,
and pruritus. Other side-effects reported rarely or very rarely include
taste disturbance, stomatitis, hepatitis, jaundice, hypersensitivity
reactions (including anaphylaxis, bronchospasm), fever, depression,
hallucinations, confusion, gynaecomastia, interstitial nephritis,
hyponatraemia, hypomagnesaemia (with long-term treatment), blood disorders
(including leucopenia, leucocytosis, pancytopenia, thrombocytopenia),
visual disturbances, sweating, photosensitivity, alopecia, Stevens-Johnson
syndrome, and toxic epidermal necrolysis. By decreasing gastric acidity,
proton pump inhibitors may increase the risk of gastro-intestinal
infections (including <span class="cAC">Clostridium difficile</span> infection).</p></div><p>Rebound acid hypersecretion and protracted dyspepsia may occur
after stopping prolonged treatment with a proton pump inhibitor.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_88867"><a href="88867.htm" title="ESOMEPRAZOLE">ESOMEPRAZOLE</a></li><li id="_17816"><a href="17816.htm" title="LANSOPRAZOLE">LANSOPRAZOLE</a></li><li id="_2138"><a href="2138.htm" title="OMEPRAZOLE">OMEPRAZOLE</a></li><li id="_56356"><a href="56356.htm" title="PANTOPRAZOLE">PANTOPRAZOLE</a></li><li id="_73247"><a href="73247.htm" title="RABEPRAZOLE SODIUM">RABEPRAZOLE SODIUM</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2134.htm">Previous: MISOPROSTOL</a> | <a class="top" href="2137.htm#">Top</a> | <a accesskey="]" href="88867.htm">Next: ESOMEPRAZOLE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>